从性别与社会性别视角看老年人多重用药、不适当处方与减药
本文综述老年人多重用药、不适当处方与减药问题,指出老年人尤其是女性药物相关伤害风险最高。文章探讨生物学性别与社会性别因素对安全处方的重要性,并提出临床可常规应用的优化用药安全实践方法。
要点
- 老年人多重用药常见,女性占多数且药物相关伤害风险最高。
- 识别潜在不适当用药与审慎减药相互关联,是优化用药安全的关键。
- 临床应常规纳入性别与社会性别因素以优化老年患者用药决策。
核心结论
- 优化老年人处方需识别潜在不适当用药并审慎减药,同时纳入性别与社会性别因素。
研究设计与样本
- 本文为综述,聚焦通过减量或停用潜在有害或不再需要的药物来优化老年处方。
主要发现
- 多重用药在老年人中非常常见,增加不适当和不安全处方的风险。
- 老年人尤其是女性药物相关伤害风险最高。
- 识别潜在不适当用药与审慎减药过程内在关联、互补且对优化用药安全至关重要。
临床怎么用
- 临床医生可将文中提供的实用方法常规应用于老年患者用药安全优化。
- 药物决策时应考虑生物学性别与社会性别因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Polypharmacy is very common in older adults and increases the risk of inappropriate and unsafe prescribing for older adults. Older adults, particularly women (who make up the majority of this age group), are at the greatest risk for drug-related harm. Therefore, optimising drug prescribing for older people is very important. Identifying potentially inappropriate medications and opportunities for judicious deprescribing processes are intrinsically linked, complementary, and essential for optimising medication safety. This Review focuses on optimising prescribing for older adults by reducing doses or stopping drugs that are potentially harmful or that are no longer needed. We explore how sex (biological) and gender (sociocultural) factors are important considerations in safe drug prescribing. We conclude by providing a practical approach to optimising medication safety that clinicians can routinely apply to the care of their older patients, highlighting how sex and gender considerations inform medication decision making.
引用
- Rochon PA, Petrovic M, Cherubini A, et al. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. Lancet Healthy Longev. 2021. PMID: 36098136. doi:10.1016/S2666-7568(21)00054-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。